Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Cash flows from operating activities:        
Net loss   $ (40,820) $ (79,489)  
Adjustments to reconcile net loss to cash used in operating activities:        
Depreciation   122 113 $ 152
Share-based compensation expense   2,633 1,674  
Gain on short-term investments     (125)  
Interest on short-term investments     (44)  
Amortization of debt discount and deferred financing costs   7,818 243  
Financing transaction costs included in financing activities $ 685 2,815    
Adjustments to fair value of derivatives 644 (1,023)    
Other   907 25  
Changes in operating assets and liabilities:        
Prepaid expenses and other current assets   3,593 1,758  
Other assets     (1,036)  
Accounts payable   (12,879) 10,487  
Accrued expenses   (10,229) 8,030  
Income taxes   (89) (7)  
Other liabilities   (683) (498)  
Net cash used in operating activities   (45,497) (58,869)  
Cash flows from investing activities:        
Purchases of property and equipment   (11) (22)  
Proceeds from sale of short-term investments     40,125  
Net cash (used) / provided by investing activities   (11) 40,103  
Cash flows from financing activities:        
Proceeds from PPP Loan   744    
Repayments of long-term debt   (4,655)    
Proceeds from private placement and rights offering, net of transactions costs   44,699    
Proceeds from registered direct offerings, net of transaction costs   8,560    
Proceeds from issuance of ordinary shares, net of transaction costs     3,037  
Proceeds from exercise of share options     60  
Net cash provided by financing activities   49,348 3,097  
Effect of exchange rates on cash and cash equivalents   (35) (29)  
Net increase in cash, cash equivalents and restricted cash   3,805 (15,698)  
Cash, cash equivalents and restricted cash, at beginning of period   4,891 44,671 44,671
Cash, cash equivalents and restricted cash, at end of period $ 8,696 8,696 28,973 $ 4,891
Supplemental Disclosure of Cash Flow Information:        
Income tax paid - US   89 402  
Interest paid   767 $ 1,067  
Exchangeable Notes        
Adjustments to reconcile net loss to cash used in operating activities:        
Interest on exchangeable notes - non-cash   $ 2,338